SMMT logo

Summit Therapeutics Inc. (SMMT) EBIT

annual EBIT:

-$211.30M-$121.57M(-135.47%)
December 31, 2024

Summary

  • As of today (August 31, 2025), SMMT annual earnings before interest & taxes is -$211.30 million, with the most recent change of -$121.57 million (-135.47%) on December 31, 2024.
  • During the last 3 years, SMMT annual EBIT has fallen by -$104.15 million (-97.20%).

Performance

SMMT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

quarterly EBIT:

-$568.44M-$501.59M(-750.30%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT quarterly earnings before interest & taxes is -$568.44 million, with the most recent change of -$501.59 million (-750.30%) on June 30, 2025.
  • Over the past year, SMMT quarterly EBIT has dropped by -$523.67 million (-1169.71%).
  • SMMT quarterly EBIT is now -1757.42% below its all-time high of $34.30 million, reached on July 31, 2018.

Performance

SMMT quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

TTM EBIT:

-$759.20M-$523.67M(-222.33%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT TTM earnings before interest & taxes is -$759.20 million, with the most recent change of -$523.67 million (-222.33%) on June 30, 2025.
  • Over the past year, SMMT TTM EBIT has dropped by -$614.67 million (-425.30%).
  • SMMT TTM EBIT is now -25133.04% below its all-time high of $3.03 million, reached on April 1, 2019.

Performance

SMMT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

SMMT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-135.5%-1169.7%-425.3%
3 y3 years-97.2%-3519.2%-677.9%
5 y5 years-284.9%-2864.3%-2274.1%

SMMT EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-166.4%at low-4284.7%at low-1044.9%at low
5 y5-year-284.9%at low-4284.7%at low-2274.1%at low
alltimeall time<-9999.0%at low-1757.4%at low<-9999.0%at low

SMMT EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$568.44M(+750.3%)
-$759.20M(+222.3%)
Mar 2025
-
-$66.85M(+1.6%)
-$235.53M(+11.5%)
Dec 2024
-$211.30M(+135.5%)
-$65.80M(+13.2%)
-$211.28M(+16.2%)
Sep 2024
-
-$58.11M(+29.8%)
-$181.88M(+25.8%)
Jun 2024
-
-$44.77M(+5.1%)
-$144.53M(+25.1%)
Mar 2024
-
-$42.60M(+17.0%)
-$115.53M(+28.7%)
Dec 2023
-$89.74M(+13.2%)
-$36.40M(+75.4%)
-$89.75M(+35.3%)
Sep 2023
-
-$20.76M(+31.6%)
-$66.31M(-2.4%)
Jun 2023
-
-$15.77M(-6.3%)
-$67.96M(+0.1%)
Mar 2023
-
-$16.82M(+29.8%)
-$67.89M(-13.0%)
Dec 2022
-$79.30M(-26.0%)
-$12.96M(-42.1%)
-$78.04M(-18.5%)
Sep 2022
-
-$22.40M(+42.6%)
-$95.71M(-1.9%)
Jun 2022
-
-$15.71M(-41.8%)
-$97.60M(-12.7%)
Mar 2022
-
-$26.96M(-12.0%)
-$111.75M(+4.3%)
Dec 2021
-$107.15M(+49.6%)
-$30.64M(+26.1%)
-$107.15M(+15.9%)
Sep 2021
-
-$24.30M(-18.6%)
-$92.44M(+4.4%)
Jun 2021
-
-$29.85M(+33.4%)
-$88.53M(+13.7%)
Mar 2021
-
-$22.37M(+40.5%)
-$77.86M(+14.0%)
Dec 2020
-$71.65M(+30.5%)
-
-
Dec 2020
-
-$15.92M(-21.9%)
-$68.29M(+30.4%)
Sep 2020
-
-$20.39M(+6.3%)
-$52.37M(+63.8%)
Jun 2020
-
-$19.18M(+49.8%)
-$31.98M(+149.8%)
Mar 2020
-
-$12.80M(<-9900.0%)
-$12.80M(<-9900.0%)
Jan 2020
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2019
-$54.90M(<-9900.0%)
-
-
Oct 2019
-
$0.00(0.0%)
-$15.46M(-50.5%)
Jul 2019
-
$0.00(0.0%)
-$31.26M(-1130.8%)
Apr 2019
-
$0.00(-100.0%)
$3.03M(-127.5%)
Jan 2019
$0.00(-100.0%)
-
-
Jan 2019
-
-$15.46M(-2.1%)
-$11.03M(-3.3%)
Oct 2018
-
-$15.80M(-146.1%)
-$11.41M(+152.9%)
Jul 2018
-
$34.30M(-343.8%)
-$4.51M(-89.8%)
Apr 2018
-
-$14.06M(-11.2%)
-$44.42M(+18.4%)
Jan 2018
-$34.56M(+6.3%)
-
-
Jan 2018
-
-$15.84M(+77.9%)
-$37.52M(+28.3%)
Oct 2017
-
-$8.90M(+58.7%)
-$29.25M(+7.8%)
Jul 2017
-
-$5.61M(-21.7%)
-$27.14M(-14.4%)
Apr 2017
-
-$7.17M(-5.3%)
-$31.71M(-5.2%)
Jan 2017
-$32.50M(-3.1%)
-
-
Jan 2017
-
-$7.56M(+11.3%)
-$33.46M(-4.5%)
Oct 2016
-
-$6.79M(-33.3%)
-$35.02M(-4.2%)
Jul 2016
-
-$10.19M(+14.4%)
-$36.55M(+9.0%)
Apr 2016
-
-$8.91M(-2.4%)
-$33.55M(+9.3%)
Jan 2016
-$33.53M(+48.8%)
-
-
Jan 2016
-
-$9.13M(+9.6%)
-$30.68M(+12.1%)
Oct 2015
-
-$8.33M(+15.9%)
-$27.37M(+43.7%)
Jul 2015
-
-$7.18M(+18.9%)
-$19.04M(+60.6%)
Apr 2015
-
-$6.04M(+3.9%)
-$11.86M(+103.9%)
Jan 2015
-$22.53M(+100.8%)
-
-
Jan 2015
-
-$5.82M(<-9900.0%)
-$5.82M(<-9900.0%)
Oct 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2014
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2014
-$11.22M
-
-
Jan 2014
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2013
-
$0.00(0.0%)
$0.00(0.0%)
DateAnnualQuarterlyTTM
Jul 2013
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2013
-$5.77M(+21.0%)
-
-
Jan 2013
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2012
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2012
-$4.77M(-17.8%)
-
-
Jan 2012
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2011
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2011
-$5.81M(-38.1%)
-
-
Jan 2011
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2010
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2010
-$9.38M(-61.1%)
-
-
Jan 2010
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2009
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2009
-$24.10M(-2.8%)
-
-
Jan 2009
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2008
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2008
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2008
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2008
-$24.81M(+199.5%)
-
-
Jan 2008
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2007
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2007
-$8.28M(+154.5%)
-
-
Jan 2007
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2006
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2006
-$3.25M(+521.3%)
-
-
Jan 2006
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2005
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2005
-$523.80K(+324.8%)
-
-
Jan 2005
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2004
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2004
-$123.30K(<-9900.0%)
-
-
Jan 2004
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2003
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2003
$0.00
$0.00(0.0%)
$0.00(0.0%)
Oct 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2002
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2002
-
$0.00
$0.00

FAQ

  • What is Summit Therapeutics Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. annual EBIT year-on-year change?
  • What is Summit Therapeutics Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. quarterly EBIT year-on-year change?
  • What is Summit Therapeutics Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. TTM EBIT year-on-year change?

What is Summit Therapeutics Inc. annual earnings before interest & taxes?

The current annual EBIT of SMMT is -$211.30M

What is the all time high annual EBIT for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high annual earnings before interest & taxes is $0.00

What is Summit Therapeutics Inc. annual EBIT year-on-year change?

Over the past year, SMMT annual earnings before interest & taxes has changed by -$121.57M (-135.47%)

What is Summit Therapeutics Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of SMMT is -$568.44M

What is the all time high quarterly EBIT for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high quarterly earnings before interest & taxes is $34.30M

What is Summit Therapeutics Inc. quarterly EBIT year-on-year change?

Over the past year, SMMT quarterly earnings before interest & taxes has changed by -$523.67M (-1169.71%)

What is Summit Therapeutics Inc. TTM earnings before interest & taxes?

The current TTM EBIT of SMMT is -$759.20M

What is the all time high TTM EBIT for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high TTM earnings before interest & taxes is $3.03M

What is Summit Therapeutics Inc. TTM EBIT year-on-year change?

Over the past year, SMMT TTM earnings before interest & taxes has changed by -$614.67M (-425.30%)
On this page